p53-mediated metabolic regulation in tumor suppression
p53-mediated metabolic regulation in tumor suppression
批准号:
10663249
负责人:
Wei Gu
金额:
$95.26万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2028-08-31
关键词:
ApoptosisCell Cycle ArrestCell physiologyDevelopmentDissectionEventGoalsHumanMalignant NeoplasmsMediatingMetabolicMetabolic PathwayMetabolismNormal CellNormal tissue morphologyPathway interactionsProgram DescriptionRegulationResearchRoleTP53 geneTissue TherapyToxic effectTumor Suppressioncancer cellcancer therapyin vivonovelprogramssenescencetranscription factortumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Inactivation of the p53 tumor suppressor is a pivotal event in the formation of most human
cancers. p53 acts as a transcription factor to modulate various types of cellular processes to
suppress cancer development. Although the classic activities of p53 including cell-cycle arrest,
senescence and apoptosis serve as critical barriers to cancer development, accumulating
evidence suggests that other unconventional mechanisms such as metabolic regulation are also
critically involved in suppressing tumor growth. Nevertheless, despite the fact that the role of the
p53 pathway in tumor suppression is indisputable, it remains a daunting task how to target this
pathway for cancer therapy. The main issue is whether activation of p53 function in vivo leads to
significant tumor regression without causing serious toxicity in normal tissues. Cancer cells rewire
cellular metabolism to meet the energetic and substrate demands of tumor development, but this
rewiring also creates metabolic vulnerabilities specific for cancer cells. By taking advantage of
these metabolic vulnerabilities, our preliminary studies showed that specific activation of the tumor
suppression function of p53 through certain metabolic targets can be effective in suppressing
tumor growth but apparently does not cause severe harm to normal tissues. The central
objective of the proposed research plan is to comprehensively define p53-mediated metabolic
regulation program that is required for its tumor suppression as a mean to identify new
targets/pathways for therapy. Toward this end, our research program will be based on two
complementary lines of research aiming to the further dissection of: 1) p53-mediated metabolic
pathways required for its tumor suppression; 2) the novel ferroptosis pathway regulated by p53
and the effects in both normal and cancer cells. We expect that the research program described
above will identify specific targets to suppress tumor growth but have minimal or at least
manageable toxicity in normal tissues.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41388-022-02331-9
发表时间:
2022-05
期刊:
ONCOGENE
影响因子:
8
作者:
[Xia, Zhangchuan, Kon, Ning, Gu, Alyssa P., Tavana, Omid, Gu, Wei]
通讯作者:
Gu, Wei
DOI:
10.18632/oncoscience.534
发表时间:
2021
期刊:
Oncoscience
影响因子:
--
作者:
[Kon N, Gu W]
通讯作者:
Gu W
DOI:
10.1126/sciadv.abi6684
发表时间:
2021-10-29
期刊:
Science advances
影响因子:
13.6
作者:
[Yang X, Wang X, Li Z, Duan S, Li H, Jin J, Zhang Z, Gu W]
通讯作者:
Gu W
DOI:
10.1038/s41467-023-37617-3
发表时间:
2023-04-06
期刊:
NATURE COMMUNICATIONS
影响因子:
16.6
作者:
[Yi, Jingjie, Tavana, Omid, Li, Huan, Wang, Donglai, Baer, Richard J., Gu, Wei]
通讯作者:
Gu, Wei
PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression.
PHLDA2 介导的磷脂酸过氧化在肿瘤抑制过程中引发独特的铁死亡反应。
DOI:
10.1016/j.cmet.2024.01.006
发表时间:
2024
期刊:
Cell metabolism
影响因子:
29
作者:
[Yang,Xin, Wang,Zhe, Samovich,SvetlanaN, Kapralov,AlexanderA, Amoscato,AndrewA, Tyurin,VladimirA, Dar,HaiderH, Li,Zhiming, Duan,Shoufu, Kon,Ning, Chen,Delin, Tycko,Benjamin, Zhang,Zhiguo, Jiang,Xuejun, Bayir,Hülya, Stockwell,BrentR, K]
通讯作者:
K
Co-regulation of p53 and PD-L1 by the VPRBP-USP2 axis in transcription and ubiquitylation
-
批准号:10439098
-
项目类别:
-
资助金额:$46.84万
-
财政年份:2022
-
负责人:Wei Gu
-
依托单位:
Co-regulation of p53 and PD-L1 by the VPRBP-USP2 axis in transcription and ubiquitylation
-
批准号:10588175
-
项目类别:
-
资助金额:$45.9万
-
财政年份:2022
-
负责人:Wei Gu
-
依托单位:
p53-mediated metabolic regulation in tumor suppression
-
批准号:10474447
-
项目类别:
-
资助金额:$95.26万
-
财政年份:2021
-
负责人:Wei Gu
-
依托单位:
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy
-
批准号:10093308
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2021
-
负责人:Wei Gu
-
依托单位:
p53-mediated metabolic regulation in tumor suppression
-
批准号:10296735
-
项目类别:
-
资助金额:$57.08万
-
财政年份:2021
-
负责人:Wei Gu
-
依托单位:
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy
-
批准号:10543758
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2021
-
负责人:Wei Gu
-
依托单位:
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy
-
批准号:10321531
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2021
-
负责人:Wei Gu
-
依托单位:
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic Acids
-
批准号:10301134
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2020
-
负责人:Wei Gu
-
依托单位:
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic Acids
-
批准号:10217044
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2020
-
负责人:Wei Gu
-
依托单位:
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic Acids
-
批准号:10456843
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2020
-
负责人:Wei Gu
-
依托单位:
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic Acids
-
批准号:9981707
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2018
-
负责人:Wei Gu
-
依托单位:
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic Acids
-
批准号:9754043
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2018
-
负责人:Wei Gu
-
依托单位:
p53 acetylation in ferroptosis and tumor suppression
-
批准号:10051413
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2017
-
负责人:Wei Gu
-
依托单位:
Mechanisms of targeting oncoprotein SET in tumor suppression
-
批准号:10117198
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2017
-
负责人:Wei Gu
-
依托单位:
Mechanisms of targeting oncoprotein SET in tumor suppression
-
批准号:9889054
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2017
-
负责人:Wei Gu
-
依托单位:
HAUSP inhibitors in p53-wild type and p53-mutant tumors
-
批准号:8861228
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2015
-
负责人:Wei Gu
-
依托单位:
HAUSP inhibitors in p53-wild type and p53-mutant tumors
-
批准号:9054821
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2015
-
负责人:Wei Gu
-
依托单位:
Regulation of SLC7A11 by p53 in cancer metabolism
-
批准号:9184541
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2015
-
负责人:Wei Gu
-
依托单位:
Mechanisms of novel cancer targets in ARF-mediated tumor suppression
-
批准号:8535139
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2012
-
负责人:Wei Gu
-
依托单位:
Regulation of Mdmx stability and subcellular localization by ubiquitination
-
批准号:8271769
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2012
-
负责人:Wei Gu
-
依托单位:
海外基金